Kangmei Pharmaceutical Co., Ltd. (600518.SS)
CNY 1.96
(2.08%)
CNY 1.96
(2.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 86.66 Million CNY | 108.55% |
| 2022 | -1.01 Billion CNY | -107.0% |
| 2021 | 14.49 Billion CNY | 858.43% |
| 2020 | -1.91 Billion CNY | -82.24% |
| 2019 | -1.04 Billion CNY | -252.64% |
| 2018 | 686.92 Million CNY | -76.19% |
| 2017 | 2.88 Billion CNY | -27.09% |
| 2016 | 3.95 Billion CNY | 22.99% |
| 2015 | 3.21 Billion CNY | 20.68% |
| 2014 | 2.66 Billion CNY | 22.35% |
| 2013 | 2.17 Billion CNY | 28.42% |
| 2012 | 1.69 Billion CNY | 47.81% |
| 2011 | 1.14 Billion CNY | 44.6% |
| 2010 | 794.04 Million CNY | 38.46% |
| 2009 | 573.48 Million CNY | 71.82% |
| 2008 | 333.78 Million CNY | 60.09% |
| 2007 | 208.49 Million CNY | 40.04% |
| 2006 | 148.87 Million CNY | 36.77% |
| 2005 | 108.85 Million CNY | 4.84% |
| 2004 | 103.82 Million CNY | 35.51% |
| 2003 | 76.62 Million CNY | 21.47% |
| 2002 | 63.07 Million CNY | 43.83% |
| 2001 | 43.85 Million CNY | 16.82% |
| 2000 | 37.54 Million CNY | 33.7% |
| 1999 | 28.07 Million CNY | 84.08% |
| 1998 | 15.25 Million CNY | 59.24% |
| 1997 | 9.57 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -58.94 Million CNY | -261.88% |
| 2024 Q2 | -16.28 Million CNY | -269.86% |
| 2024 Q1 | 9.58 Million CNY | -95.75% |
| 2023 Q3 | -21.75 Million CNY | 67.38% |
| 2023 Q2 | -66.69 Million CNY | -31.62% |
| 2023 FY | 86.66 Million CNY | 108.55% |
| 2023 Q1 | -50.67 Million CNY | 96.58% |
| 2023 Q4 | 225.78 Million CNY | 1137.94% |
| 2022 Q1 | -108.68 Million CNY | -100.98% |
| 2022 Q4 | -1.48 Billion CNY | -1175.55% |
| 2022 Q2 | -88.79 Million CNY | 18.29% |
| 2022 FY | -1.01 Billion CNY | -107.0% |
| 2022 Q3 | -116.07 Million CNY | -30.72% |
| 2021 Q1 | -601.2 Million CNY | 97.86% |
| 2021 FY | 14.49 Billion CNY | 858.43% |
| 2021 Q2 | -305.99 Million CNY | 49.1% |
| 2021 Q3 | -96.52 Million CNY | 68.45% |
| 2021 Q4 | 11.11 Billion CNY | 11614.43% |
| 2020 Q1 | -317.72 Million CNY | 92.01% |
| 2020 Q2 | -1.11 Billion CNY | -249.8% |
| 2020 Q4 | -28.1 Billion CNY | -2835.99% |
| 2020 Q3 | -957.24 Million CNY | 13.87% |
| 2020 FY | -1.91 Billion CNY | -82.24% |
| 2019 Q2 | -143.44 Million CNY | -149.6% |
| 2019 Q4 | -3.97 Billion CNY | -10866.9% |
| 2019 Q3 | -36.27 Million CNY | 74.71% |
| 2019 FY | -1.04 Billion CNY | -252.64% |
| 2019 Q1 | 289.2 Million CNY | 107.52% |
| 2018 Q3 | 1.44 Billion CNY | 3.69% |
| 2018 FY | 686.92 Million CNY | -76.19% |
| 2018 Q1 | 1.69 Billion CNY | 294.0% |
| 2018 Q2 | 1.39 Billion CNY | -17.78% |
| 2018 Q4 | -3.84 Billion CNY | -366.18% |
| 2017 Q4 | -873.29 Million CNY | -173.15% |
| 2017 Q1 | 1.43 Billion CNY | 61.5% |
| 2017 Q2 | 1.13 Billion CNY | -21.04% |
| 2017 FY | 2.88 Billion CNY | -27.09% |
| 2017 Q3 | 1.19 Billion CNY | 5.5% |
| 2016 Q1 | 1.17 Billion CNY | 61.76% |
| 2016 FY | 3.95 Billion CNY | 22.99% |
| 2016 Q4 | 887.47 Million CNY | -8.91% |
| 2016 Q3 | 974.3 Million CNY | 5.26% |
| 2016 Q2 | 925.6 Million CNY | -20.91% |
| 2015 FY | 3.21 Billion CNY | 20.68% |
| 2015 Q4 | 723.49 Million CNY | -8.98% |
| 2015 Q3 | 794.84 Million CNY | 9.28% |
| 2015 Q2 | 727.34 Million CNY | -25.19% |
| 2015 Q1 | 972.24 Million CNY | 42.67% |
| 2014 Q1 | 798.72 Million CNY | 50.39% |
| 2014 FY | 2.66 Billion CNY | 22.35% |
| 2014 Q4 | 681.47 Million CNY | 8.43% |
| 2014 Q3 | 628.47 Million CNY | 12.68% |
| 2014 Q2 | 557.73 Million CNY | -30.17% |
| 2013 FY | 2.17 Billion CNY | 28.42% |
| 2013 Q3 | 520.81 Million CNY | 12.65% |
| 2013 Q1 | 665.1 Million CNY | 31.76% |
| 2013 Q2 | 462.31 Million CNY | -30.49% |
| 2013 Q4 | 531.1 Million CNY | 1.98% |
| 2012 Q2 | 362.25 Million CNY | -23.94% |
| 2012 Q1 | 476.29 Million CNY | 58.22% |
| 2012 Q3 | 353.67 Million CNY | -2.37% |
| 2012 Q4 | 504.8 Million CNY | 42.73% |
| 2012 FY | 1.69 Billion CNY | 47.81% |
| 2011 FY | 1.14 Billion CNY | 44.6% |
| 2011 Q4 | 301.04 Million CNY | 9.56% |
| 2011 Q3 | 274.78 Million CNY | 6.82% |
| 2011 Q2 | 257.24 Million CNY | -18.35% |
| 2011 Q1 | 315.07 Million CNY | 30.31% |
| 2010 Q1 | 196.9 Million CNY | -2.12% |
| 2010 Q3 | 187 Million CNY | 11.09% |
| 2010 Q4 | 241.79 Million CNY | 29.3% |
| 2010 FY | 794.04 Million CNY | 38.46% |
| 2010 Q2 | 168.33 Million CNY | -14.51% |
| 2009 Q4 | 201.17 Million CNY | 68.68% |
| 2009 Q2 | 126.64 Million CNY | 0.19% |
| 2009 FY | 573.48 Million CNY | 71.82% |
| 2009 Q3 | 119.26 Million CNY | -5.82% |
| 2009 Q1 | 126.39 Million CNY | 38.53% |
| 2008 Q2 | 90.41 Million CNY | 15.15% |
| 2008 Q1 | 78.52 Million CNY | 29.49% |
| 2008 FY | 333.78 Million CNY | 60.09% |
| 2008 Q4 | 91.23 Million CNY | 23.97% |
| 2008 Q3 | 73.59 Million CNY | -18.6% |
| 2007 Q4 | 60.63 Million CNY | 11.16% |
| 2007 FY | 208.49 Million CNY | 40.04% |
| 2007 Q1 | 33.41 Million CNY | -12.58% |
| 2007 Q3 | 54.54 Million CNY | -8.92% |
| 2007 Q2 | 59.89 Million CNY | 79.24% |
| 2006 Q3 | 41.31 Million CNY | -4.47% |
| 2006 FY | 148.87 Million CNY | 36.77% |
| 2006 Q1 | 26.09 Million CNY | -9.4% |
| 2006 Q2 | 43.24 Million CNY | 65.74% |
| 2006 Q4 | 38.22 Million CNY | -7.49% |
| 2005 Q3 | 27.55 Million CNY | -8.16% |
| 2005 Q1 | 22.48 Million CNY | -16.24% |
| 2005 Q4 | 28.8 Million CNY | 4.51% |
| 2005 FY | 108.85 Million CNY | 4.84% |
| 2005 Q2 | 30 Million CNY | 33.44% |
| 2004 Q4 | 26.84 Million CNY | -7.3% |
| 2004 Q3 | 28.96 Million CNY | -10.17% |
| 2004 Q2 | 32.24 Million CNY | 104.31% |
| 2004 Q1 | 15.77 Million CNY | -32.29% |
| 2004 FY | 103.82 Million CNY | 35.51% |
| 2003 Q3 | 14.85 Million CNY | -36.96% |
| 2003 Q1 | 14.89 Million CNY | -27.5% |
| 2003 FY | 76.62 Million CNY | 21.47% |
| 2003 Q2 | 23.56 Million CNY | 58.24% |
| 2003 Q4 | 23.3 Million CNY | 56.87% |
| 2002 Q3 | 15.54 Million CNY | 3.44% |
| 2002 Q2 | 15.02 Million CNY | 25.57% |
| 2002 Q1 | 11.96 Million CNY | 0.0% |
| 2002 FY | 63.07 Million CNY | 43.83% |
| 2002 Q4 | 20.54 Million CNY | 32.15% |
| 2001 FY | 43.85 Million CNY | 16.82% |
| 2000 FY | 37.54 Million CNY | 33.7% |
| 1999 FY | 28.07 Million CNY | 84.08% |
| 1998 FY | 15.25 Million CNY | 59.24% |
| 1997 FY | 9.57 Million CNY | 0.0% |